Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 754 evidences · page 16 / 71

7 %The prevalence of the 39A substitution in reverse transcriptase sequences was 7% among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

0,2 odds_ratioThe summary odds ratio between non-autoimmune diabetes and HGV infection risk was 0.2 (95% CI: 0–6.2) based on one study.

CamerounHepatitis G (HGV) · non-autoimmune diabetes mellituspublié 2021Scientific reportseurope_pmcdocument de 11 observationsDOI 10.1038/s41598-021-88598-6

59 %The proportion of participants receiving diabetes education increased from 59.0% to 78.3%.

Cameroundiabète de type 2observé 2005-2017publié 2020Diabetologiaeurope_pmcdocument de 2 observations

4,9 %Type 2 diabetes prevalence among 20-79-year-olds in the Africa Region (AFR) was 4.9% in 2013.

Cameroundiabète de type 2observé 2013publié 2014Diabetes research and clinical practiceeurope_pmcdocument de 14 observations

50,3 %The overall Plasmodium prevalence was 50.3% as detected by microscopy.

Camerounpaludismeobservé November 2020publié 2023Parasites & vectorseurope_pmcdocument de 16 observationsDOI 10.1186/s13071-022-05635-7

8,6 %Baseline HbA1c is 8.6±2.5% in Cameroon.

Cameroundiabète (non précisé)publié 2017The Pan African medical journaleurope_pmcdocument de 7 observations

39 %Metabolic syndrome was associated with increased overall mortality both after 1 year (39% vs. 9%) and 5 years of follow-up (55% vs. 26%, p = 0.022).

CamerounAVC · syndrome métaboliquepublié 2013PloS oneeurope_pmcdocument de 6 observations

1,26 hazard_ratioHIV-positive patients over 39 years old had a hazard ratio of 1.26 for early antiretroviral treatment initiation.

CamerounVIH/sidaobservé 2014publié 2020Health Policy and PlanningOpenAlexdocument de 6 observationsDOI 10.1093/heapol/czaa153

10 %In 2010, high cholesterol was responsible for more than 10% of deaths from cardiovascular diseases, chronic kidney disease, and diabetes.

Cameroundiabète (non précisé) · high cholesterol · maladie rénale chronique · maladies cardiovasculairesobservé 2010publié 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument de 28 observationsDOI 10.1016/s2213-8587(14)70102-0

7,9 %The death rate from non-communicable diseases (NCDs) decreased globally by 7.9% between 2007 and 2017.

Camerounmaladies non transmissiblesobservé 2007 to 2017publié 2018Lancet (London, England)europe_pmcdocument de 15 observations

0,8 mm_Hg_per_decadeGlobally, between 1980 and 2008, systolic blood pressure decreased by 0.8 mm Hg per decade in men.

Camerounhypertension artérielleobservé 1980–2008publié 2011Lancet (London, England)europe_pmcdocument de 10 observations

27 %Seroreactivity to B19 virus was recorded in 27% of gorillas.

CamerounB19 viruspublié 2010Journal of VirologyOpenAlexdocument de 10 observations

4,2 %Le paludisme représente 4,2 % de la mortalité chez les enfants de moins de 5 ans au Cameroun selon une enquête réalisée en 2004.

Camerounpaludismeobservé 2004HAL · Unilimdocument de 98 observations

200 per_100000In 2010, age-standardised death rates from cardiovascular diseases, chronic kidney disease, and diabetes attributable to the combined effects of high blood pressure, high BMI, high glucose, and high cholesterol were less than 200 deaths per 100 000 for men in Spain.

Cameroundiabète (non précisé) · maladie rénale chronique · maladies cardiovasculairesobservé 2010publié 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument de 28 observationsDOI 10.1016/s2213-8587(14)70102-0

5,8 %Two HBV seroprevalence studies in pregnant women were conducted in Cameroon and Zimbabwe, in which a prevalence of 5.8% and 2.7%, respectively, was reported.

Camerounhépatite Bpublié 2024Frontiers in public healthPubMeddocument de 4 observations

10 176 casEn 2015, près de 10 176 cas suspects de paludisme grave ont été hospitalisés à Bafia, avec 58 décès.

Camerounpaludismeobservé 2015HAL · Unilimdocument de 67 observations

Cardiovascular, respiratory, and related disorders (CVRDs) are the leading causes of adult death worldwide.

Camerouncardiovascular, respiratory, and related disorders (CVRDs)publié 2018Lancet (London, England)europe_pmcdocument de 2 observationsDOI 10.1016/s0140-6736(17)32471-6

2 000 professionnelsLe programme de formation de la Fondation Pierre Fabre vise plus de 2 000 professionnels (médecins, infirmiers, sages-femmes) et 3 000 étudiants en Côte d’Ivoire, en République Démocratique du Congo, en Centrafrique et au Cameroun.

Cameroun · RDCdrépanocytoseHAL · Unilimdocument de 857 observations

40 %Among the 40 patients studied, 16 (40.0%) presented with left ventricular hypertrophy.

Cameroundiabète de type 2publié 2001Diabetes & metabolismeurope_pmcdocument de 6 observations

57,29 %The frequency of multiclonal infections was 57.29% in Tibati, Cameroon.

CamerounpaludismeHAL · Unilimdocument de 106 observations

2,1 aOROn multivariate analysis, female gender was associated with an adjusted odds ratio of 2.1 (95% CI 1.2–3.8) for vertical HIV transmission.

CamerounVIH/sidaobservé November 2007 to October 2010publié 2019Paediatrics and international child healthPubMeddocument de 7 observations

0 %The age-standardized control rate for coincident hypertension and diabetes was 0% among women in a semi-urban population in Bafoussam, Cameroon.

Cameroundiabète (non précisé) · hypertension artérielleobservé 2012publié 2014BMC public healtheurope_pmcdocument de 24 observationsDOI 10.1186/1471-2458-14-696

0 %Overall prevalence was low in apes (n = 1,418), ranging from 0% for USUV-NS1 to 2.6% for CHIKV-E2.

Camerounchikungunyapublié 2021PLoS neglected tropical diseasesOpenAlexdocument de 8 observationsDOI 10.1371/journal.pntd.0009028

En zone urbaine, le paludisme est hypo endémique.

CamerounpaludismeHAL · Unilimdocument de 98 observations

11,1 %Diabetes prevalence in 2021 was estimated to be 11.1% in high-income countries.

Cameroundiabète (non précisé)observé 2021publié 2022Diabetes research and clinical practiceeurope_pmcdocument de 7 observationsDOI 10.1016/j.diabres.2021.109119

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.